Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer
-
Published:2024-01
Issue:
Volume:5
Page:5-5
-
ISSN:2218-6778
-
Container-title:Translational Breast Cancer Research
-
language:
-
Short-container-title:Transl Breast Cancer Res
Publisher
AME Publishing Company